Articles Tagged With:
-
Communication Is Major Contributing Factor to ED Malpractice Claims
Emergency department (ED) malpractice claims frequently contain allegations that delayed diagnoses led to poor outcomes or death. “Many times, the primary contributing factor is lack of communication,” according to Jacqueline Ross, RN, PhD, coding director in the department of patient safety and risk management at The Doctors Company.
-
Experts Offer Roadmap for Improving Care of Patients with Sickle Cell Disease in the ED
When a patient with sickle cell disease (SCD) presents to the ED, it is likely because he or she is experiencing excruciating pain from a vaso-occlusive episode — a condition that occurs when sickle-shaped red blood cells get stuck while traveling through small blood vessels, impeding blood flow.
-
Redesigned Processes Help System Better Manage Surge in Patients with Behavioral Health Concerns
While EDs across the country saw a surge in patients with behavioral health concerns during the pandemic, Norfolk, VA-based Sentara Health, a system which includes 15 hospitals across the state, faced added pressures contributing to the phenomenon.
-
Clinical Pathways Combat Mental Health Stigma in EDs
Standardized, evidence-based clinical pathways are an effective approach to combat stigma toward individuals with mental illness in the ED setting, reports Nasuh Malas, MD, MPH, division director and service chief of Child and Adolescent Psychiatry at University of Michigan Health System.
-
Stigma Toward Mental Illness Poses Safety Risks for ED Patients
Stigma toward patients with mental illness is common among ED nurses, a recent study found.
-
Emergency Physician Defendants Get Help from Peer Support Model
Many emergency physicians (EPs) named in lawsuits are emotionally derailed by the process, and experience anxiety, frustration, and insomnia as a result.
-
Measles: Identify Potential Cases, Move Swiftly to Prevent Exposures
In just the first three months of this year, there were already more confirmed measles cases in the United States than in all of 2023, according to the Centers for Disease Control and Prevention (CDC).
-
What Are Those T Waves?
The patient whose ECG appears in the figure presented to an ambulatory care clinic for chest pain. Is the patient likely to have hyperkalemia?
-
Iloprost Injection (Aurlumyn)
The U.S. Food and Drug Administration has approved iloprost for the treatment of severe frostbite to reduce the risk of amputation of fingers or toes. Iloprost, a synthetic analog of prostaglandin, initially was approved in 2004 for the treatment of pulmonary arterial hypertension. For that indication, it was given a priority review, accelerated approval, breakthrough therapy, and orphan drug designations. Iloprost for the frostbite indication is distributed by Eicos Sciences as Aurlumyn.
-
Empowered Relief vs. CBT vs. Health Education for Low Back Pain
This randomized clinical trial involving adults with chronic low back pain demonstrates that a single session of a pain management class, when compared to a full course of cognitive behavioral therapy, yields noninferior (clinically on par) outcomes in pain catastrophizing and several other measures at the three-month follow-up.